2022 PSI Annual Conference
The PSI 2022 Conference took place at Gothia Towers, Gothenburg, Sweden from 12th to 15th June.
The conference consisted of a variety of plenary and parallel sessions, as well as breakout discussion sessions, workshops, a poster session and the Annual General Meeting. The conference ran over three full days from Monday to Wednesday, with a choice from two optional half day training course on the Sunday afternoon.
The 2022 Conference was a great success and was the highest attended PSI conference to date. Thank you to everyone involved; speakers, poster presenters, delegates, exhibitors, sponsors, MCI and the PSI scientific committee, for contributing to another successful conference.
David Lawrence, 2022 PSI Conference Chair
Kate Taylor, 2022 PSI Conference Vice-Chair
Paul Terrill, 2021 PSI Conference Vice-Chair
To access the recorded sessions from the PSI 2022 Conference, please visit our Video on Demand homepage.
To source the Conference content, simply select 'PSI 2022 Conference' from the 'Collection' dropdown menu. This will filter all available content to only show on-demand sessions from the 2022 Conference.
Please note: these are only available to view for Members of PSI, and will need to be signed in to watch them.
Some of this year's sessions are unfortunately not available to view on-demand, however we have made the slide decks available. Please see Session Titles listed below, with slide decks available to download beneath.
Please note: these are only accessible for Members of PSI, and will need to be signed in to access them.
Dealing with Non-Proportional Hazards
Everything better on average Calculating sample sizes based on average hazard ratio
Group-sequential stratified weighted log-rank tests in immuno-oncology
Estimands in Practice
Implementing Estimand Framework – Not So Simple!
Roche's estimand journey what we have learned and our future plans
Single World Intervention Graphs for Defining, Identifying, and Communicating Estimands in Clinical Trials
FMS (Swedish Society for Medical Statistics)
Selection bias and multiple inclusion criteria in observational studies
Statistical approaches and considerations when using an external control arm for a rare disease project
Travel vaccines strongly reduce mortality in cancer patients – a real effect or residual confounding
Bayesian sample size planning for basket trials permitting borrowing of information
Phase II Basket Trials with Pruning and Pooling as Compared to Bayesian Hierarchical Models
Statistical catalysts Influencing an Externally Sponsored platform trial in COVID-19
Designing an Adaptive Platform Trial in Tuberculosis
Drug combination development to treat infectious diseases Piranga platform trial case study
The EU-PEARL framework to design and conduct platform trials.
The TOGETHER Platform Trial - A multi-center, adaptive, randomized, platform trial to evaluate the effect of repurposed medicines in outpatient
PSI/RSS Prize-Winner's Session
Strategies for improving the assessment of probability of success (PoS) in late stage drug development
Using R for Regulatory Work
Using R for Regulatory Work (combined slides)
Historical Data SIG - framework part 1
Part 1 slides
Launch & Lifecycle SIG - are medical affairs the wild west of statistics
Are medical affairs the wild west of statistics (combined slides)
RWD SIG - Opportunities and Methodological Challenges
Alexander Schacht and Elizabeth Merrall's Slides
Deepak Parashar's slides